BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36451812)

  • 1. Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing.
    Xiao M; Zhang X; Zhang D; Deng S; Zheng A; Du F; Shen J; Yue L; Yi T; Xiao Z; Zhao Y
    Front Immunol; 2022; 13():1050951. PubMed ID: 36451812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance.
    Wang C; Li Y; Jia L; Kim JK; Li J; Deng P; Zhang W; Krebsbach PH; Wang CY
    Cell Stem Cell; 2021 Sep; 28(9):1597-1613.e7. PubMed ID: 33945793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
    Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
    Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
    Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
    J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis.
    Pei S; Chen L; Yang Y; Zhu X
    Head Neck; 2020 Sep; 42(9):2460-2472. PubMed ID: 32459022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell sequencing of head and neck carcinoma: Transcriptional landscape and prognostic model based on malignant epithelial cell features.
    Xiong M; Hu JJ; Yao ML; Song TT; Zhao L; Mou BQ; Qian YX; Zheng MJ; Dong YJ; Wang HY; Zou J; Yang H
    FASEB J; 2024 Jan; 38(1):e23354. PubMed ID: 38085162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma.
    Lin W; Xu Y; Gao J; Zhang H; Sun Y; Qiu X; Huang Q; Kong L; Lu JJ
    Front Immunol; 2021; 12():757047. PubMed ID: 34675936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
    Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
    Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Aspects of Head and Neck Squamous Cell Carcinoma: Cancer Stem Cells, their Niche and Targeted Therapy.
    Küçükgüven MB; Çelebi-Saltik B
    Curr Stem Cell Res Ther; 2021; 16(3):286-306. PubMed ID: 32957904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Plasticity-Targeted Therapy in Head and Neck Cancers.
    Shang W; Zhang Q; Huang Y; Shanti R; Alawi F; Le A; Jiang C
    J Dent Res; 2018 Jun; 97(6):654-664. PubMed ID: 29486673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PVT1 inhibition stimulates anti-tumor immunity, prevents metastasis, and depletes cancer stem cells in squamous cell carcinoma.
    Qin Z; Zhang W; Liu S; Wang Y; Peng X; Jia L
    Cell Death Dis; 2023 Mar; 14(3):187. PubMed ID: 36894542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
    Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3-mediated ALDH m
    Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
    Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identity matters: cancer stem cells and tumour plasticity in head and neck squamous cell carcinoma.
    Salem A; Salo T
    Expert Rev Mol Med; 2023 Feb; 25():e8. PubMed ID: 36740973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.